NanoString Technologies

NanoString Technologies, Inc. is a publicly traded biotechnology company that specializes in the development and commercialization of tools for genomics and transcriptomics research, as well as diagnostic products. Founded in 2003, NanoString's technology enables a wide range of research and diagnostic applications, including the measurement of gene expression, single-cell analysis, and digital pathology.

History[edit | edit source]

NanoString Technologies was established based on technology developed by scientists at the Institute for Systems Biology in Seattle, Washington. The company has since grown to become a key player in the life sciences sector, offering products that facilitate the analysis of biological data at a molecular level.

Technology[edit | edit source]

The core technology behind NanoString's products is the nCounter Analysis System, which allows for the direct measurement of hundreds of nucleic acids in a single reaction without the need for PCR amplification. This system uses color-coded molecular barcodes and single molecule imaging to detect and count hundreds of unique transcripts in a single reaction. The technology is known for its high level of precision and reproducibility, making it a valuable tool for researchers.

Applications[edit | edit source]

NanoString's products are used in a variety of research areas, including cancer research, neuroscience, and immunology. The company's technology facilitates the discovery and validation of new biomarkers, the study of gene regulation, and the understanding of complex diseases at the molecular level.

Diagnostic Products[edit | edit source]

In addition to research tools, NanoString has developed diagnostic products that leverage its technology for use in clinical settings. One of the notable products is the Prosigna® Breast Cancer Prognostic Gene Signature Assay, which is used to assess a patient's risk of recurrence of breast cancer.

Business Model[edit | edit source]

NanoString operates on a business model that includes the sale of instruments, consumables, and software for research use, as well as the development of diagnostic products for clinical use. The company has established a global sales and distribution network to support its diverse customer base.

Challenges and Opportunities[edit | edit source]

As with many companies in the biotechnology sector, NanoString faces challenges such as intense competition, rapid technological advancements, and the need to continuously innovate. However, the company's unique technology and broad application spectrum provide significant opportunities for growth in both the research and clinical markets.

Conclusion[edit | edit source]

NanoString Technologies, Inc. represents a key player in the field of genomics and transcriptomics, offering innovative solutions that advance the understanding of genetics and molecular biology. Through its development of cutting-edge technology and diagnostic products, NanoString continues to contribute to the advancement of personalized medicine and the broader life sciences field.

NanoString Technologies Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.